Porter et al.,68 in this prospective pilot study, examined how use of rtCGM impacts glycemic metrics, weight loss, lifestyle, and patient perspectives on using the sensor among 37 T2D adults not treated with prandial insulin.68 Participants were randomized to either lifestyle counseling with two 10-day sessions of rtCGM use in blinded mode (n = 22) or four 10-day sessions of rtCGM use in unblinded mode but with no counseling (n = 15); 13 rtCGM participants completed the study. Here, INS is linked to type 2 diabetes mellitus.